Adjuvant imatinib mesylate in patients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: Safety results from the US Intergroup Phase II trial ACOSOG Z9000 Meeting Abstract
| Authors: | DeMatteo, R. P.; Antonescu, C. R.; Chadaram, V.; You, Y. N.; McCall, L.; Maki, R.; Murgo, A.; Demetri, G.; Pisters, P.; Brennan, M. F. |
| Abstract Title: | Adjuvant imatinib mesylate in patients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: Safety results from the US Intergroup Phase II trial ACOSOG Z9000 |
| Meeting Title: | 41st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 23 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2005 May 13-17 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2005-06-01 |
| Start Page: | 818S |
| Language: | English |
| ACCESSION: | WOS:000230326605313 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2005.23.16_suppl.9009 |
| Notes: | --- - Meeting Abstract: 9009 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
